Patent-family-84389346
Applicants:
- NMD PHARMA AS [NORA names: Other Companies; Private Research]
Abstract
The present disclosure relates to compounds suitable for treating, ameliorating and/or preventing neuromuscular disorders, including the reversal of drug-induced neuromuscular blockade. The compounds as defined herein can inhibit the CIC-1 ion channel.
Patent Family Records (1)
COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS
NMD PHARMA AS KELLY NICHOLAS MICHAEL, KNUTSEN LARS J S, SARASWAT NEERJA, (...more)
2024, WO-2024121129-A1